Abbott Labs Com (ABT) Stake Maintained by Assetmark Inc; Knightsbridge Asset Management Lowered Its Position in Apple (AAPL) by $2.81 Million

January 14, 2018 - By Adrian Mccoy

Assetmark Inc increased its stake in Abbott Labs Com (ABT) by 16.83% based on its latest 2017Q3 regulatory filing with the SEC. Assetmark Inc bought 13,673 shares as the company’s stock declined 3.42% while stock markets rallied. The institutional investor held 94,910 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $5.06 million, up from 81,237 at the end of the previous reported quarter. Assetmark Inc who had been investing in Abbott Labs Com for a number of months, seems to be bullish on the $102.42B market cap company. The stock decreased 0.19% or $0.11 during the last trading session, reaching $58.84. About 6.32 million shares traded or 6.93% up from the average. Abbott Laboratories (NYSE:ABT) has risen 15.90% since January 14, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.

Knightsbridge Asset Management Llc decreased its stake in Apple Inc (AAPL) by 27.26% based on its latest 2017Q3 regulatory filing with the SEC. Knightsbridge Asset Management Llc sold 18,258 shares as the company’s stock rose 12.78% with the market. The institutional investor held 48,730 shares of the computer manufacturing company at the end of 2017Q3, valued at $7.51M, down from 66,988 at the end of the previous reported quarter. Knightsbridge Asset Management Llc who had been investing in Apple Inc for a number of months, seems to be less bullish one the $900.87 billion market cap company. The stock increased 1.03% or $1.81 during the last trading session, reaching $177.09. About 25.42 million shares traded. Apple Inc. (NASDAQ:AAPL) has risen 62.48% since January 14, 2017 and is uptrending. It has outperformed by 45.78% the S&P500.

Since August 7, 2017, it had 0 insider buys, and 12 sales for $93.68 million activity. Riccio Daniel J. also sold $2.65M worth of Apple Inc. (NASDAQ:AAPL) shares. FEDERIGHI CRAIG also sold $9.98M worth of Apple Inc. (NASDAQ:AAPL) on Monday, August 7. Srouji Johny also sold $948,612 worth of Apple Inc. (NASDAQ:AAPL) on Monday, August 28. 6,209 shares were sold by KONDO CHRIS, worth $1.01 million. The insider SEWELL D BRUCE sold $5.00 million. Another trade for 63,388 shares valued at $9.78M was sold by AHRENDTS ANGELA J.

Investors sentiment increased to 0.7 in Q3 2017. Its up 0.02, from 0.68 in 2017Q2. It improved, as 52 investors sold AAPL shares while 1034 reduced holdings. 116 funds opened positions while 640 raised stakes. 2.97 billion shares or 2.78% less from 3.06 billion shares in 2017Q2 were reported. Sfmg Ltd Company reported 2.02% of its portfolio in Apple Inc. (NASDAQ:AAPL). Putnam Fl Investment Management holds 3.59% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 244,429 shares. Seizert Cap Ptnrs Lc holds 392,775 shares. Lafleur Godfrey Ltd Liability Company has invested 7.07% in Apple Inc. (NASDAQ:AAPL). 74,236 were accumulated by Natixis Asset. Great Lakes Advsrs Ltd Liability Co stated it has 638,954 shares. Contravisory Management holds 0.2% or 3,582 shares in its portfolio. Citadel Limited Liability Co invested 0.06% in Apple Inc. (NASDAQ:AAPL). 68,879 were reported by Fulton Breakefield Broenniman Limited Liability. 2,741 are held by Rosenblum Silverman Sutton S F Ca. Transamerica Financial Advisors Incorporated holds 0.77% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 40,229 shares. 17,018 were accumulated by Lenox Wealth Mgmt. Motley Fool Wealth Mngmt Ltd accumulated 104,923 shares or 1.38% of the stock. Davis R M reported 465,707 shares. Quinn Opportunity Prtn Limited invested in 97,500 shares.

Among 52 analysts covering Apple Inc. (NASDAQ:AAPL), 40 have Buy rating, 1 Sell and 11 Hold. Therefore 77% are positive. Apple Inc. had 344 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was reinitiated by Rosenblatt on Friday, September 11 with “Buy”. The firm has “Buy” rating given on Thursday, July 13 by Goldman Sachs. The stock of Apple Inc. (NASDAQ:AAPL) has “Hold” rating given on Tuesday, December 19 by Nomura. CLSA maintained it with “Buy” rating and $115 target in Wednesday, April 27 report. Piper Jaffray maintained Apple Inc. (NASDAQ:AAPL) on Friday, May 26 with “Buy” rating. On Friday, November 3 the stock rating was maintained by Robert W. Baird with “Outperform”. KeyBanc Capital Markets upgraded the stock to “Overweight” rating in Monday, October 16 report. Citigroup maintained the shares of AAPL in report on Wednesday, December 13 with “Buy” rating. The rating was maintained by Brean Capital on Friday, September 11 with “Buy”. On Friday, October 13 the stock rating was maintained by Barclays Capital with “Equal-Weight”.

Analysts await Apple Inc. (NASDAQ:AAPL) to report earnings on January, 30. They expect $3.75 earnings per share, up 11.61% or $0.39 from last year’s $3.36 per share. AAPL’s profit will be $19.08 billion for 11.81 P/E if the $3.75 EPS becomes a reality. After $2.07 actual earnings per share reported by Apple Inc. for the previous quarter, Wall Street now forecasts 81.16% EPS growth.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 92 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, March 1. The stock of Abbott Laboratories (NYSE:ABT) has “Buy” rating given on Friday, July 21 by Deutsche Bank. Stifel Nicolaus maintained the shares of ABT in report on Friday, September 22 with “Buy” rating. The stock of Abbott Laboratories (NYSE:ABT) earned “Outperform” rating by RBC Capital Markets on Friday, January 29. The stock of Abbott Laboratories (NYSE:ABT) has “Equal-Weight” rating given on Monday, January 4 by Morgan Stanley. The stock of Abbott Laboratories (NYSE:ABT) has “Buy” rating given on Thursday, August 4 by Jefferies. On Tuesday, September 13 the stock rating was maintained by Jefferies with “Buy”. As per Tuesday, August 15, the company rating was maintained by Cowen & Co. The stock of Abbott Laboratories (NYSE:ABT) has “Buy” rating given on Tuesday, September 5 by Jefferies. The company was maintained on Monday, October 2 by BMO Capital Markets.

Assetmark Inc, which manages about $13.57B and $8.79 billion US Long portfolio, decreased its stake in Spdr Series Trust Blomberg Intl Tr (BWX) by 195,037 shares to 407,931 shares, valued at $11.46M in 2017Q3, according to the filing. It also reduced its holding in Corning Inc Com (NYSE:GLW) by 57,155 shares in the quarter, leaving it with 1,976 shares, and cut its stake in Boston Properties Inc Com (NYSE:BXP).

Since August 1, 2017, it had 0 insider purchases, and 6 sales for $22.86 million activity. 2,000 shares were sold by Bracken Sharon J, worth $98,323. Fussell Stephen R also sold $9.73M worth of Abbott Laboratories (NYSE:ABT) shares. Contreras Jaime also sold $2.74M worth of Abbott Laboratories (NYSE:ABT) shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts